Answers are grounded in this paper and cite their sources.
Withdrawal and storage of faricimab in syringes for up to day 37 did not impair the structure and bi-specific binding properties of the therapeutic antibody.
No takes yet. Share an insight, caveat, or question.
Jørstad et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: